A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 (1000/10mg) in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2018
At a glance
- Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
- Indications Diabetes mellitus; Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 14 Nov 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Oct 2018 to 1 Dec 2018.
- 25 Oct 2018 Status changed from not yet recruiting to recruiting.
- 05 Oct 2018 New trial record